SciELO - Scientific Electronic Library Online

 
vol.20 issue4Prognostic factors of remission in patients with acute lymphoblastic leukemia after a first relapse author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cancerología

Print version ISSN 0123-9015

Abstract

MEDINA GOMEZ, Laura María; VASQUEZ PALACIO, Gonzalo  and  MUNETON PENA, Carlos Mario. Methylation analysis of the CDKN2B and DBC1 tumour suppressor genes in leukaemia patients in Colombia. rev.colomb.cancerol. [online]. 2016, vol.20, n.4, pp.150-158. ISSN 0123-9015.  http://dx.doi.org/10.1016/j.rccan.2016.09.002.

Objective: To perform a methylation analysis in the CDKN2B and DBC1 gene promoters in samples from Colombian patients with acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML), and chronic myeloid leukaemia (CML), and to correlate the methylation profile with cytogenetic findings. Material and methods: The study included a total of 56 bone marrow samples, 24 from patients with ALL, 16 from AML patients, and 16 from CML patients. DNA was extracted from these samples and converted with sodium bisulphite. Methylation analysis was performed using methylation specific PCR (MS-PCR). The samples that were positive for MS-PCR were sequenced to confirm the results. Results: A total methylation frequency of 87.5% was found. CDKN2B gene promoter hypermethylation was found in 75% of ALL and CML samples, and 62% in AML; while DBC1 gene promoter hypermethylation was found in 96% of the samples of ALL, 94% of AML, and in 68.8% of CML. The most frequently methylated gene in all samples was DBC1. ALL was the type of leukaemia that had the highest percentages of methylation. Almost two-thirds (62.5%) of the samples had both methylated genes. Samples with normal karyotype had a high frequency of methylation in CDKN2B and DBC1 genes. Conclusions: This study showed, for the first time in Colombian patients with leukaemia, that methylation of DBC1 and CDKN2B genes is a common event. Our findings indicate that methylation of tumour suppressor genes is an alternate genetic pathway related to the development of haematological malignancies.

Keywords : DNA methylation; Leukaemia; ALL; AML; CML; Epigenetics; Tumour suppressor genes.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )